A patent-focused intellectual property boutique, with an emphasis on biotech and pharmaceuticals, Groombridge Wu Baughman & Stone got off to a roaring start in 2023 as entity calving off from Paul Weiss with a trial-centric approach and a wave of peer review fueling its market momentum. “This is an IP shop to watch,” advises one peer. “They broke off and took all of their clients with them, and they are steadfastly loyal because [Groombridge Wu] can try cases.” Another elaborates, “They get hired for cases of some enterprise significance. They skew largely in favor of life sciences. There’s a great balance there of Nicholas Groombridge, the polished, eloquent, seasoned statesman, and the group of other name partners (Eric Stone, Steven Baughman and Jennifer Wu), who are younger and really roll up their sleeves and get involved in the trenches.” A client addresses Groombridge as a “great litigator and a consummate gentleman, very professional and great to work with.” Stone is championed for his “Integrity and strategic thinking.” It is also noted that “Groombridge Wu is really growing its younger ranks, although to be fair, it could be said that these people are growing the firm! There is some real brain power there.”
A firm team, composed of Groombridge, Steve Baughman and Jennifer Wu, is lead counsel for plaintiffs 10x and Stanford University in litigation in the District of Delaware asserting six patents on key technology relating to single-cell sequencing. The team is also lead counsel for 10x in defending the validity of the six patents at the PTAB. The defendant is a competitor to 10x in the single-cell-sequencing market. The team logged wins in three of the six IPRs, convincing the PTAB not to institute. The team also received a unique ruling conditionally terminating two of the instituted IPRs. The firm’s PTAB team, led by Steve Baughman and Megan Raymond, acted for Novo Nordisk, successfully defeating institution of two IPR challenges to patents for the active compound in the blockbuster Ozempic drug in October 2023.
